Concord Biotech approves first 1:1 bonus issue
In short
Concord Biotech Limited approved its first-ever 1:1 bonus issue on September 23. The stock rose nearly 2% after the news.
The move has caught investor attention. The reporting does not say the record date or give any other terms.
What the reporting says
Concord Biotech Limited approved its first-ever 1:1 bonus issue on September 23, according to the report, and the stock rose nearly 2% after the announcement. The source says the move has drawn investor interest, but it does not provide the record date or any other terms. The immediate consequence is a modest share-price gain, while the broader shareholder impact is still not fully stated.
Why it matters
Concord Biotech’s board approved a 1:1 bonus issue, and the market response was a nearly 2% rise in the stock. A bonus issue increases the number of shares held without changing the company’s underlying business, but the report does not provide the record date or full timetable. The news is relevant to current shareholders and traders watching the stock.